Use App
New
Connect your Agent
Trending
News
Earnings
All
DIA
0.18%
SPY
0.18%
QQQ
0.24%
Trending
FUN
2.50%
CRCL
1.54%
TEM
0.81%
BRUN
0.07%
XLE
0.35%
FNMA
9.01%
DJT
3.05%
IBRX
UPS
0.11%
HOOD
0.63%
Feed
News
Sentiment
Earnings
Fundamentals
Info
home
Symbol
BTSG
news
Exchange:
NASDAQ
·
Updated 07:30 PM EDT
BTSG News
News
all
press releases
Here's Why You Should Add BrightSpring Stock to Your Portfolio Now
BTSG's specialty pharmacy, infusion and home-based care expansion support growth, while IRA and execution risks may put pressure on near-term margins.
Zacks
Share to Feed
More News
BTSG Gains More Than 54% YTD: Should You Buy, Hold or Sell?
BrightSpring Health Services has surged 54% YTD on specialty pharmacy, infusion and EBITDA growth, but premium valuation and policy headwinds remain.
Zacks
BTSG's Specialty Pharmacy Sales Up 30%: Will the Growth Continue?
BrightSpring Health Services' Specialty and Infusion sales rose 30%, backed by LDD growth, new launches and expansion into rare therapies.
Zacks
Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth?
BrightSpring Health Services is gaining acute infusion share with 20%+ volume growth, targeting 12-15 new states in a $20 billion market.
Zacks
NVIDIA & 2 Profitable Stocks to Buy in September for Big Upside
NVDA's 63.7% net profit margin and 93.3% expected earnings growth put it among three profitable stocks positioned for market volatility.
Zacks
Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year?
Here is how Avantor, Inc. (AVTR) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
Zacks
Here's Why Investors Should Stay Neutral on TDOC Stock for Now
Teladoc Health's growth is supported by chronic care, international expansion and Teladoc One, but BetterHelp weakness and losses temper the outlook.
Zacks
Here's Why Investors Should Retain Molina Healthcare Stock for Now
MOH's contract wins, acquisitions and cash generation support growth, but elevated medical costs and valuation pose risks.
Zacks
Here's Why Investors Should Retain Humana Stock for Now
HUM benefits from Medicare Advantage growth, CenterWell expansion and strong cash generation, but rising costs and debt remain concerns.
Zacks
Best Momentum Stocks to Buy for August 26th
BTSG, ANIK and OPHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 26th, 2026.
Zacks
1
2
Advertisement
|
Remove ads.
Home
Watchlist
Trending
News
Explore
Profile